Eastwood Bio-Medical Canada Inc.
EBM
Rank in Stocks
#20163
Eastwood Bio-Medical Canada Inc., established in Richmond, Canada, in 2010, is... Eastwood Bio-Medical Canada Inc., established in Richmond, Canada, in 2010, is a company focused on the worldwide marketing and distribution of natural health products. Operating under the Eleotin brand, their offerings are available across Canada, the United States, and Asian regions. The firm's core mission is to deliver natural remedies for prevalent metabolic disorders, including issues with blood glucose regulation, hypertension, and obesity. Their extensive portfolio of licensed Eleotin products addresses diverse health requirements. For individuals experiencing spleen deficiency, appetite loss, or fatigue, Eleotin A 700 provides support. Eleotin AL88 serves as a laxative, while Eleotin Cal20 aids in the maintenance of healthy bones and teeth. Eleotin V3D is formulated for the development and upkeep of strong bones, teeth, and overall well-being. To support cardiovascular health, they offer Eleotin G2000. Eleotin H55 is designed to act as a sedative and alleviate tension, and Eleotin Zn330 is vital for tissue formation and metabolic processes. Furthermore, their product line includes Eleotin Bentley, which promotes balanced glucose levels, and Eleotin LBM, intended for hypertension relief.
Share Price
$1.30
Last synced: 2026-11-09
Market Cap
$89.76M
Change (1 day)
2.22%
Change (1 year)
199.46%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Eastwood Bio-Medical Canada Inc. (EBM)
Category
Healthcare
Operating Margin for Eastwood Bio-Medical Canada Inc. (EBM)
Operating Margin as of November 2026 TTM: -33.24%
According to Eastwood Bio-Medical Canada Inc.'s latest financial reports, its current operating margin (TTM) is -33.24%. At the end of 2025 the company had an operating margin of -45.35%.
Operating Margin history for Eastwood Bio-Medical Canada Inc. from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -33.24% | -26.70% |
| 2025 | -45.35% | -22.09% |
| 2023 | -58.21% | 485.03% |
| 2022 | -9.95% | -83.62% |
| 2021 | -60.74% | -48.78% |
| 2020 | -118.59% | 226.87% |
| 2019 | -36.28% | -48.31% |
| 2018 | -70.19% | -41.05% |
| 2017 | -119.07% | 12.43% |
| 2016 | -105.91% | 376.86% |
| 2015 | -22.21% | -73.23% |
| 2014 | -82.96% | 241.12% |
| 2013 | -24.32% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 3.66% | -100.11% |
US
|
|
| 3.21% | -100.10% |
US
|
|
| 1.31% | -100.04% |
US
|
|
| 5.52% | -100.17% |
ZA
|
|
| 4.32% | -100.13% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Eastwood Bio-Medical Canada Inc.'s operating margin
What is Eastwood Bio-Medical Canada Inc.'s operating margin?
Eastwood Bio-Medical Canada Inc.'s operating margin is -33.24%, as of Nov 2026.
What was Eastwood Bio-Medical Canada Inc.'s operating margin in 2025?
In 2025, Eastwood Bio-Medical Canada Inc.'s operating margin was -45.35%, compared with -58.21% in 2023.
How has Eastwood Bio-Medical Canada Inc.'s operating margin changed since 2020?
From 2020 to 2025, Eastwood Bio-Medical Canada Inc.'s operating margin was highest in 2022 (-9.95%) and lowest in 2020 (-118.59%).
How does Eastwood Bio-Medical Canada Inc.'s operating margin compare with similar companies?
Eastwood Bio-Medical Canada Inc.'s operating margin (-33.24%) is lower than that of all 5 similar companies listed above. The highest among them is Bid Corporation Limited, with 5.52%.